Induced pluripotent stem cell-derived cardiac myocytes to assess anthracycline cardiotoxicity

Back

ESC Professional Premium Access

Induced pluripotent stem cell-derived cardiac myocytes to assess anthracycline cardiotoxicity

Session: Basic research in cardio-oncology

Topic: Cardio-Oncology

Speaker: Doctor L. Van Aelst (Leuven, BE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Lucas Van Aelst

University Hospitals (UZ) Leuven, Leuven (Belgium)

0 follower

6 more presentations in this session

Biomimetic nanozymes target the heart to suppress ferroptosis for ameliorating doxorubicin-induced cardiotoxicity via synergetic effect of antioxidant stress and Nrf2/Hmox1 inhibition

Speaker: Professor T. Liu (Tianjin, CN)

Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

Speaker: Doctor J. Shanmuganathan (Aalborg, DK)

Mitochondrial function and oxidative stress in isolated peripheral blood mononuclear cells and trastuzumab-induced cardiotoxicity: a prospective longitudinal study

Speaker: Assistant Professor K. Leemasawat (Chiang Mai, TH)

Circulating SerpinA3 as a novel indicator of cardiovascular dysfunction after anthracycline chemotherapy

Speaker: Doctor H. Boen (Antwerp, BE)

Protective effects of nicotinamide mononucleotide on radiation-related cardiac injury

Speaker: Professor T. Liu (Tianjin, CN)

Access the full session

Basic research in cardio-oncology

Speakers: Doctor L. Van Aelst, Professor T. Liu, Doctor J. Shanmuganathan, Assistant Professor K. Leemasawat, Doctor H. Boen...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources